当前位置:首页 - 行情中心 - 三诺生物(300298) - 财务分析 - 现金流量表

三诺生物

(300298)

  

流通市值:74.45亿  总市值:92.50亿
流通股本:4.51亿   总股本:5.60亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,203,883,454.764,972,518,406.693,640,108,982.042,314,897,963.05
  收到的税费返还10,176,373.5737,459,740.7436,665,596.8732,707,979.78
  收到其他与经营活动有关的现金10,217,871.5364,349,868.0441,995,812.4630,888,700.98
  经营活动现金流入小计1,224,277,699.865,074,328,015.473,718,770,391.372,378,494,643.81
  购买商品、接受劳务支付的现金470,465,838.631,889,558,168.671,254,446,571.76831,951,659.65
  支付给职工以及为职工支付的现金358,767,043.251,212,570,383.93919,419,480.46630,306,905.15
  支付的各项税费73,123,402.55306,526,118.8208,583,504.18148,759,718.9
  支付其他与经营活动有关的现金276,027,125.081,060,528,775.49799,091,861.31494,111,528.48
  经营活动现金流出小计1,178,383,409.514,469,183,446.893,181,541,417.712,105,129,812.18
  经营活动产生的现金流量净额45,894,290.35605,144,568.58537,228,973.66273,364,831.63
二、投资活动产生的现金流量:
  收回投资收到的现金-34,452,466.0234,452,466.0224,116,726.21
  取得投资收益收到的现金832,536.931,580,438.221,154,018.21831,286.13
  处置固定资产、无形资产和其他长期资产收回的现金净额56,363.286,858.754,649.615,285.95
  收到的其他与投资活动有关的现金105,080,067.951,241,291,973.12929,194,855.15545,843,936.97
  投资活动现金流入小计105,968,968.081,277,411,736.06964,855,988.98570,807,235.26
  购建固定资产、无形资产和其他长期资产支付的现金38,764,904.66198,871,579.45155,758,536.5127,379,358.13
  投资支付的现金3,297,683---
  取得子公司及其他营业单位支付的现金--122,967.08--
  支付其他与投资活动有关的现金50,000,0001,372,554,877.351,082,815,470.03494,101,866.61
  投资活动现金流出小计92,062,587.661,571,303,489.721,238,574,006.53621,481,224.74
  投资活动产生的现金流量净额13,906,380.42-293,891,753.66-273,718,017.55-50,673,989.48
三、筹资活动产生的现金流量:
  取得借款收到的现金81,002,288.92421,740,381.86288,150,542.75149,435,572.65
  收到其他与筹资活动有关的现金-1,089,811.72--
  筹资活动现金流入小计81,002,288.92422,830,193.58288,150,542.75149,435,572.65
  偿还债务支付的现金113,283,133.48442,567,639.2292,770,692.47252,000,000
  分配股利、利润或偿付利息支付的现金1,181,706.19136,787,579.63125,138,472.5123,146,682.61
  其中:子公司支付给少数股东的股利、利润-1,679,238.19--
  支付其他与筹资活动有关的现金102,032,170.11219,185,675.82140,277,183.1188,769,928.82
  筹资活动现金流出小计216,497,009.78798,540,894.65558,186,348.08463,916,611.43
  筹资活动产生的现金流量净额-135,494,720.86-375,710,701.07-270,035,805.33-314,481,038.78
四、汇率变动对现金及现金等价物的影响-8,270,355.53-7,126,733.52-1,918,721.911,870,204.87
五、现金及现金等价物净增加额-83,964,405.62-71,584,619.67-8,443,571.13-89,919,991.76
  加:期初现金及现金等价物余额770,870,272.55842,454,892.22842,454,892.22842,454,892.22
  期末现金及现金等价物余额686,905,866.93770,870,272.55834,011,321.09752,534,900.46
补充资料:
  净利润-22,076,674.05-182,071,127.84
  资产减值准备-195,074,989.94--3,859,586.47
  固定资产和投资性房地产折旧-142,387,334.51-68,589,588.51
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-142,387,334.51-68,589,588.51
  无形资产摊销-39,286,500.11-20,809,759.48
  长期待摊费用摊销-5,524,808.79-2,599,615.03
  处置固定资产、无形资产和其他长期资产的损失-1,143,532.66-325,746.84
  公允价值变动损失--1,345,429.99--
  财务费用-41,795,122.03-18,799,668.78
  投资损失--1,401,010.78--825,810.72
  递延所得税--15,704,014.13-47,192.6
  其中:递延所得税资产减少--15,170,721.67--299,478.65
    递延所得税负债增加--533,292.46-346,671.25
  存货的减少--108,959,165.66--45,761,721.73
  经营性应收项目的减少-92,671,491.6--75,065,319.29
  经营性应付项目的增加-177,132,967.17-97,999,960.35
  现金的期末余额-770,870,272.55-752,534,900.46
  减:现金的期初余额-842,454,892.22-842,454,892.22
  现金及现金等价物的净增加额--71,584,619.67--89,919,991.76
公告日期2026-04-282026-04-282025-10-242025-08-28
审计意见(境内)标准无保留意见
TOP↑